These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6233587)

  • 1. [Current treatment of pulmonary tuberculosis].
    Bollinelli R
    Presse Med; 1984 Jun; 13(23):1427-9. PubMed ID: 6233587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myrin P in the combined treatment of tuberculosis].
    Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD; Zeliger LR; Elistratova NA
    Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis treatment today].
    Sjögren I; Boman G; Löfdahl CG; Skoogh BE
    Lakartidningen; 1984 Dec; 81(49):4655-9. PubMed ID: 6521569
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for tuberculosis today.
    Stead WW; Dutt AK
    Am Rev Respir Dis; 1982 Mar; 125(3 Pt 2):94-101. PubMed ID: 7041725
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in antituberculosis chemotherapy.
    Chan SL
    Xianggang Hu Li Za Zhi; 1979 Nov; (27):19-27. PubMed ID: 317480
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of chemotherapy on the care of patients with tuberculosis.
    Johnston RF; Wildrick KH
    Am Rev Respir Dis; 1974 Jun; 109(6):636-64. PubMed ID: 4209115
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of pulmonary tuberculosis].
    Schmidt M
    Dtsch Med Wochenschr; 1992 Dec; 117(49):1886-8. PubMed ID: 1459017
    [No Abstract]   [Full Text] [Related]  

  • 8. Relapse rates in tuberculosis patients.
    de Villiers CL; Macnab MF
    S Afr Med J; 1995 Feb; 85(2):114-5. PubMed ID: 7597522
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of tuberculosis for patients with renal impairment.
    Ellard GA
    Nephron; 1993; 64(2):169-81. PubMed ID: 8321347
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of tuberculosis].
    Ben Amar J; Dhahri B; Aouina H; Azzabi S; Baccar MA; El Gharbi L; Bouacha H
    Rev Pneumol Clin; 2015; 71(2-3):122-9. PubMed ID: 25434510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
    Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
    Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
    Babalik A; Ulus IH; Bakirci N; Kuyucu T; Arpag H; Dagyildizi L; Capaner E
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5740-2. PubMed ID: 23979746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
    Pätiälä J; Tani P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):123-8. PubMed ID: 4128939
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
    Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR
    East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of tuberculosis: altered role of the primary care physician.
    Hinshaw HC
    Postgrad Med; 1977 Apr; 61(4):52-8. PubMed ID: 850669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective anti-tuberculosis therapy correlates with plasma small RNA.
    Honeyborne I; Lipman MC; Eckold C; Evangelopoulos D; Gillespie SH; Pym A; McHugh TD
    Eur Respir J; 2015 Jun; 45(6):1741-4. PubMed ID: 25745052
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
    Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
    Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
    [No Abstract]   [Full Text] [Related]  

  • 20. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.